Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Elblag – page 2

120 clinical trials in Elblag, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Elblag at a glance
120
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

120 trials in Elblag

Open in trial search

Study of Elafibranor for Adults with Primary Biliary Cholangitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.

Crohn's disease

Recruiting

Study on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:MORF-057
  • Sponsor:Morphic Therapeutic Inc.

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational
Countries:PolandPoland
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Lunsekimig
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Long‑Term Safety and Efficacy of RO7790121 in Adults with Moderate to Severe Rheumatoid Arthritis: Extension Study

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Obesity+1

Recruiting

A study to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight and type 2 diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 sodium
  • Sponsor:Eli Lilly & Co.

A study to evaluate the efficacy and safety of orforglipron in patients with peripheral artery disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Study on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Lutikizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on the Effects of Upadacitinib for Patients with Active Psoriatic Arthritis and Axial Spondyloarthritis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:Care Arthritis Ltd.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Elblag

What the registry says about research in the country

01 Dermatological Conditions

Research focusing on plaque psoriasis and innovative treatments for moderate to severe cases. Studies evaluating novel therapeutic approaches for atopic dermatitis.

  • Moderate to Severe Plaque Psoriasis
  • Atopic Dermatitis Management

Multiple trials investigating long-term safety and efficacy of new therapeutic agents.

02 Rheumatological Studies

Comprehensive research into psoriatic arthritis treatments, including studies for both biologic-naive and experienced patients. Additional focus on Sjögren's Syndrome and innovative therapies.

  • Active Psoriatic Arthritis
  • Primary Sjögren's Disease
  • Rotator Cuff Tendinopathy

Evaluating multiple therapeutic approaches for autoimmune conditions.

03 Metabolic and Respiratory Research

Studies addressing obesity and weight management through innovative treatments. Research on respiratory conditions including RSV infections and asthma management.

  • Obesity and Weight Management
  • Respiratory Syncytial Virus
  • Asthma Control

Focus on both preventive measures and therapeutic interventions.

04 Gastrointestinal Studies

Investigations into treatments for Crohn's Disease and Ulcerative Colitis, focusing on innovative therapeutic approaches for inflammatory bowel conditions.

  • Moderately to Severely Active Crohn's Disease
  • Ulcerative Colitis Management

Evaluating new therapeutic options for inflammatory bowel diseases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.